Why does the medication information sheet mention a potential risk of cancer?
- The medical fact sheet primarily lists side effects related to daily dosing for transplant patients. Our intermittent low dosing every 7 days avoids immune suppression. Rapamycin inhibits mTOR, exhibiting anti-cancer properties by preventing cell proliferation and inflammatory conditions conducive to cancer.
Does Healthspan test medications for purity and bioavailability?
- Healthspan prioritizes medication purity and effectiveness. Our rapamycin tablets meet strict U.S. quality standards and are compounded at an FDA-inspected U.S. pharmacy.
How is the dose of the Rapamycin protocol determined?
- Dosage is dependent on many factors, including weight-based dosing and clinical assessment.